Search results
Goldman Sachs: Citigroup strategic transformation plan gains momentum By Investing.com
Investing.com· 17 hours agoGoldman Sachs analysts remain positive on Citigroup (C) following the company's investor day, with...
Royal Bank of Canada Boosts Citigroup (NYSE:C) Price Target to $66.00
ETF DAILY NEWS· 4 days agoOther analysts have also issued research reports about the company. Oppenheimer reduced their target price on Citigroup from $87.00 to $86.00 and set an ...
Rubrik (NYSE:RBRK) PT Raised to $47.00 at Citigroup
ETF DAILY NEWS· 6 days agoRubrik (NYSE:RBRK – Get Free Report) had its target price lifted by equities researchers at Citigroup from $46.00 to $47.00 in a research report issued...
Expensify, Inc. (NASDAQ:EXFY) Receives $4.20 Consensus Price Target from Brokerages
ETF DAILY NEWS· 6 hours agoOne investment analyst has rated the stock with a sell recommendation, four have given a hold...
Citigroup Increases Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $64.00
ETF DAILY NEWS· 1 day agoReport) had its target price boosted by equities research analysts at Citigroup from $38.00 to $64.00 in a research report issued to clients and investors ...
Morgan Stanley says ‘crown jewel’ of Citi is worth half the bank’s value
Fortune via AOL· 11 hours agoWhile Citi’s stock has increased 14 percent this year to $60.62, analysts at Oppenheimer and Wells...
First Hawaiian Bank Sells 2,118 Shares of Citigroup Inc. (NYSE:C)
ETF DAILY NEWS· 23 hours agoThe firm owned 20,091 shares of the company’s stock after selling 2,118 shares during the period. First Hawaiian Bank’s holdings in Citigroup were worth ...
Citigroup Lowers Dayforce (NYSE:DAY) Price Target to $66.00
ETF DAILY NEWS· 1 day agoCitigroup’s price objective suggests a potential upside of 34.26% from the company’s previous close. DAY has been the subject of several other research ...
Citigroup (C) Exceeds Market Returns: Some Facts to Consider
Zacks· 3 days agoFree Report) closed at $60.78, marking a +1.2% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.25%. The the stock of U.S. bank ...
Ovid Therapeutics (NASDAQ:OVID) Price Target Cut to $1.20
ETF DAILY NEWS· 1 day agoHC Wainwright dropped their target price on Ovid Therapeutics from $9.00 to $3.00 and set a “buy” rating on the stock in a research report on Tuesday. Wedbush ...